HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huanfa Yi Selected Research

Huanfa Yi Research Topics

Disease

13Neoplasms (Cancer)
05/2020 - 06/2009
3Neoplasm Metastasis (Metastasis)
04/2013 - 11/2011
3Melanoma (Melanoma, Malignant)
04/2013 - 04/2011
2Autoimmune Diseases (Autoimmune Disease)
12/2020 - 04/2008
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2020
2Rheumatoid Arthritis
01/2020 - 01/2020
2Carcinogenesis
01/2020 - 01/2019
2Experimental Melanoma
04/2013 - 09/2011
2Prostatic Neoplasms (Prostate Cancer)
11/2012 - 03/2011
2Infections
04/2012 - 06/2009
2Atherosclerosis
04/2012 - 06/2009
1Chronic Obstructive Pulmonary Disease (COPD)
01/2022
1Multiple Sclerosis
12/2020
1Necrosis
05/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2020
1Adenocarcinoma of Lung
01/2020
1Osteoporosis
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Dacryocystitis (Dacryoadenitis)
01/2020
1Dry Eye Syndromes (Dry Eye Syndrome)
01/2020
1Colitis
01/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Glioma (Gliomas)
01/2019
1Inflammation (Inflammations)
01/2019
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2019
1Uveitis
11/2016
1Hepatitis
01/2013
1Disease Progression
11/2012
1Pathologic Processes
04/2012
1Shock
04/2012
1Alzheimer Disease (Alzheimer's Disease)
04/2012
1Vesicular Stomatitis
04/2011
1Virus Diseases (Viral Diseases)
04/2011

Drug/Important Bio-Agent (IBA)

6Scavenger Receptors (Scavenger Receptor)IBA
01/2020 - 06/2009
5AntigensIBA
04/2013 - 03/2011
4Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2020
4VaccinesIBA
01/2018 - 09/2011
2Biological ProductsIBA
05/2020 - 01/2020
2Estrogens (Estrogen)FDA Link
01/2020 - 01/2020
2Therapeutic UsesIBA
01/2020 - 01/2020
2Interleukin-17 (Interleukin 17)IBA
01/2020 - 11/2016
2Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2012 - 09/2011
1SmokeIBA
01/2022
1Pharmaceutical PreparationsIBA
12/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2020
1MethylprednisoloneFDA LinkGeneric
12/2020
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
12/2020
1Anti-Allergic Agents (Antiallergic Agents)IBA
12/2020
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2020
1QuercetinIBA
05/2020
1CateninsIBA
01/2020
1ArginaseIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Lysine (L-Lysine)FDA Link
01/2020
1Circular RNAIBA
01/2020
1curculigosideIBA
01/2020
1NitrogenIBA
01/2020
116S Ribosomal RNAIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2020
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
01/2020
1Histones (Histone)IBA
01/2020
1ChromatinIBA
01/2020
1celastrol methyl esterIBA
01/2019
1AutoantibodiesIBA
01/2019
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2019
1Small Interfering RNA (siRNA)IBA
01/2019
1MicroRNAs (MicroRNA)IBA
01/2019
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
01/2019
1Interleukin-33IBA
01/2018
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2016
1interstitial retinol-binding proteinIBA
11/2016
1FlagellinIBA
04/2013
1InterleukinsIBA
04/2013
1glucose-regulated protein 170IBA
04/2013
1Concanavalin AIBA
01/2013
1GemcitabineFDA Link
11/2012
1CytokinesIBA
11/2012
1CPG-oligonucleotideIBA
04/2012
1Neoplasm Antigens (Tumor Antigens)IBA
09/2011
1Proteins (Proteins, Gene)FDA Link
09/2011
1Antiviral Agents (Antivirals)IBA
04/2011
1Toll-Like Receptor 3IBA
04/2011
1H-Y AntigenIBA
03/2011
1Interleukin-2 (IL2)IBA
03/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
06/2009
1AntibodiesIBA
04/2008

Therapy/Procedure

6Immunotherapy
05/2020 - 03/2011
5Therapeutics
05/2020 - 04/2013
1Drug Therapy (Chemotherapy)
01/2020
1Radiotherapy
11/2012
1Cell- and Tissue-Based Therapy (Cell Therapy)
03/2011
1Organ Transplantation
04/2008